- Home
- TRST vs CRGX Comparison
TRST vs CRGX Comparison
Compare TRST & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- CRGX
- Stock Information
- Founded
- TRST 1902
- CRGX 2021
- Country
- TRST United States
- CRGX United States
- Employees
- TRST N/A
- CRGX N/A
- Industry
- TRST Major Banks
- CRGX
- Sector
- TRST Finance
- CRGX
- Exchange
- TRST Nasdaq
- CRGX Nasdaq
- Market Cap
- TRST 642.6M
- CRGX 621.4M
- IPO Year
- TRST N/A
- CRGX 2023
- Fundamental
- Price
- TRST $32.22
- CRGX $12.39
- Analyst Decision
- TRST
- CRGX Strong Buy
- Analyst Count
- TRST 0
- CRGX 6
- Target Price
- TRST N/A
- CRGX $31.80
- AVG Volume (30 Days)
- TRST 117.4K
- CRGX 287.3K
- Earning Date
- TRST 01-21-2025
- CRGX 11-12-2024
- Dividend Yield
- TRST 4.47%
- CRGX N/A
- EPS Growth
- TRST N/A
- CRGX N/A
- EPS
- TRST 2.48
- CRGX N/A
- Revenue
- TRST $168,593,000.00
- CRGX N/A
- Revenue This Year
- TRST N/A
- CRGX N/A
- Revenue Next Year
- TRST $11.69
- CRGX N/A
- P/E Ratio
- TRST $12.99
- CRGX N/A
- Revenue Growth
- TRST N/A
- CRGX N/A
- 52 Week Low
- TRST $25.83
- CRGX $10.91
- 52 Week High
- TRST $38.89
- CRGX $33.92
- Technical
- Relative Strength Index (RSI)
- TRST 41.09
- CRGX 39.66
- Support Level
- TRST $30.15
- CRGX $10.91
- Resistance Level
- TRST $32.94
- CRGX $15.75
- Average True Range (ATR)
- TRST 0.87
- CRGX 1.20
- MACD
- TRST 0.04
- CRGX -0.11
- Stochastic Oscillator
- TRST 53.91
- CRGX 30.08
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.